Orthocell Ltd
ASX:OCC

Watchlist Manager
Orthocell Ltd Logo
Orthocell Ltd
ASX:OCC
Watchlist
Price: 0.64 AUD -3.76% Market Closed
Market Cap: 153m AUD
Have any thoughts about
Orthocell Ltd?
Write Note

Orthocell Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Orthocell Ltd
Net Income (Common) Peer Comparison

Comparables:
MSB
CSL
CUV
TLX
PYC

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Orthocell Ltd
ASX:OCC
Net Income (Common)
-AU$7.2m
CAGR 3-Years
7%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Net Income (Common)
-$88m
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Net Income (Common)
$2.6B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
7%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Net Income (Common)
AU$35.6m
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Net Income (Common)
AU$5.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PYC Therapeutics Ltd
ASX:PYC
Net Income (Common)
-AU$37.7m
CAGR 3-Years
-29%
CAGR 5-Years
-56%
CAGR 10-Years
-28%

See Also

What is Orthocell Ltd's Net Income (Common)?
Net Income (Common)
-7.2m AUD

Based on the financial report for Jun 30, 2024, Orthocell Ltd's Net Income (Common) amounts to -7.2m AUD.

What is Orthocell Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-4%

Over the last year, the Net Income (Common) growth was -15%. The average annual Net Income (Common) growth rates for Orthocell Ltd have been 7% over the past three years , -4% over the past five years .

Back to Top